Treating Advanced Sarcoma: One Size Does Not Fit All
1 意见
• 07/18/23
0
0
嵌入
Dr. Nikhil Khushalani, Section Chief of Soft Tissue and Melanoma & Director of the IL-2 Program, Department of Medicine, RPCI, gives an overview of the treatment strategies used in advanced soft tissue sarcoma, including a new drug, approved by the FDA in April 2012, called pazopanib.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论